Jonathan L. Powell, MD


Nemours Children's Hospital, Delaware 1600 Rockland Road Wilmington, DE 19803


  • Hematology/Oncology - The Children's Hospital of Philadelphia, 2004

Internship Residency

  • Pediatrics - The Children's Hospital of Philadelphia, 2001

Medical/Dental School

  • MD - University of Texas Southwestern Medical Center, 1998

Board Certifications

  • American Board of Pediatrics/Hematology-Oncology

  • Successful Crizotinib-Targeted Therapy of Pediatric Unresectable ERC1::ALK Fusion Sarcoma; Unknown Source; (2023).

    View Full Publication
  • Sporadic extranodal Rosai-Dorfman-Destombes disease treated with tocilizumab; Pediatric Blood & Cancer; (2022).

    View Full Publication
  • Fusion-negative rhabdomyosarcoma with diffuse bony metastases and remarkable chemosensitivity; BMJ Case Reports; (2022).

    View Full Publication
  • Aggressive Hematopoietic Malignancy Characterized by Biallelic Loss of SMARCB1; JCO Precision Oncology; (2020).

    View Full Publication
  • A novel and successful therapeutic approach in the treatment of a patient with simultaneous relapsed Ewing sarcoma and therapy-related acute myeloid leukemia; Pediatric Blood & Cancer; (2020).

    View Full Publication
  • Immunodeficiency and bone marrow failure with mosaic and germline TLR8 gain-of-function; Blood; (2020).

    View Full Publication
  • Topical Amphotericin B in Combination With Standard Therapy for Severe Necrotizing Skin and Soft-Tissue Mucormycosis in an Infant With Bilineal Leukemia; Journal of Pediatric Hematology/Oncology; (2014).

    View Full Publication
  • An unexpectedly high incidence of Epstein-Barr virus lymphoproliferative disease after CD34+ selected autologous peripheral blood stem cell transplant in neuroblastoma; Bone Marrow Transplantation; (2004).

    View Full Publication